Literature DB >> 17851242

Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.

A Hakansson1, A Medvedeo, M Andersson, M Berglund.   

Abstract

Buprenorphine misuse by injecting drug users was assessed in a survey of 350 needle exchangers, either amphetamine (57%) or heroin users (42%). 89% of heroin users and 24% of amphetamine users reported using buprenorphine at some time during the previous year. Most users reported illicit acquisition. Among illicit users, 87% of heroin users reported intake for withdrawal treatment or self-detoxification, and 11% for euphoria. Euphoria seeking was more common among amphetamine users (62%, p < 0.001). Intravenous misuse was reported by 43% of illicit users, and snorting by 29%. Sole sublingual intake was more common among heroin users than among amphetamine users (46 vs. 20%, p < 0.05), and less common among patients reporting euphoria seeking (20 vs. 46%, p < 0.05).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17851242     DOI: 10.1159/000104883

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  19 in total

1.  Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy.

Authors:  Enrico Moratti; Hamid Kashanpour; Tiziana Lombardelli; Maria Maisto
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 2.  A review of human drug self-administration procedures.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

3.  Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users.

Authors:  Jermaine D Jones; Maria A Sullivan; Suzanne K Vosburg; Jeanne M Manubay; Shanthi Mogali; Verena Metz; Sandra D Comer
Journal:  Addict Biol       Date:  2014-07-25       Impact factor: 4.280

4.  Buprenorphine treatment for narcotic addiction: not without risks.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2015 Mar-Apr

5.  The reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users.

Authors:  Jermaine D Jones; Gabriela Madera; Sandra D Comer
Journal:  Pharmacol Biochem Behav       Date:  2014-05-02       Impact factor: 3.533

Review 6.  Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.

Authors:  Michael A Yokell; Nickolas D Zaller; Traci C Green; Josiah D Rich
Journal:  Curr Drug Abuse Rev       Date:  2011-03

7.  Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.

Authors:  Alexander R Bazazi; Michael Yokell; Jeannia J Fu; Josiah D Rich; Nickolas D Zaller
Journal:  J Addict Med       Date:  2011-09       Impact factor: 3.702

8.  Route of administration for illicit prescription opioids: a comparison of rural and urban drug users.

Authors:  April M Young; Jennifer R Havens; Carl G Leukefeld
Journal:  Harm Reduct J       Date:  2010-10-15

9.  Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.

Authors:  David Otiashvili; Gvantsa Piralishvili; Zura Sikharulidze; George Kamkamidze; Sabrina Poole; George E Woody
Journal:  Drug Alcohol Depend       Date:  2013-07-31       Impact factor: 4.492

10.  The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs.

Authors:  Stephanie Lake; Kanna Hayashi; Jane Buxton; M-J Milloy; Huiru Dong; Evan Wood; Julio Montaner; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2015-09-30       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.